Doppel
Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.
News & Highlights
Doppel Pharma CDMO and its commitment towards Rare Diseases and Orphan Drugs
Doppel perspective on Orphan drugs According to the US Food and Drug Administration (FDA), an orphan drug is defined as one "intended for the treatment, prevention or diagnosis of a [...]
Doppel Pharma CDMO delivers first commercial batches of generic temperature stable Nitisinone capsules to the USA
Milan, July 4th 2022 Doppel Pharma CDMO is pleased to announce that on June 24th, it has delivered to Dipharma the first commercial batches of generic temperature stable Nitisinone capsules [...]
Doppel Pharma CDMO delivered the first validation & Commercial batches of Ravidasvir
On March 8th Doppel Pharma CDMO delivered the first validation & Commercial batches of Ravidasvir, to be commercialized in Malaysia for the treatment of Hepatitis C. Hepatitis C is a [...]
Environmental KPI
OVERALL SCORE
ENVIRONMENT
LABOR & HUMAN RIGHTS
ETHICS
SUSTAINABLE PROCUREMENT
Corporate history highlights
The company is committed to applying its innovative technologies, deep knowledge and broad experience to develop products of the highest quality for its customers worldwide.
Doppel has a strong track record in building and forging close partnerships with its customers. The company works very closely with its partners to provide high quality services tailored to the specific needs of each individual customer at all stages from formulation, development and manufacturing all the way to marketing and post-marketing controls.
In particular, Doppel provides a specialist consultative service to customers prior to each project in order to determine together the most effective and bespoke solution for the product.